Image

Addressing Hypertension Care in Africa Program

Addressing Hypertension Care in Africa Program

Recruiting
18-70 years
All
Phase N/A

Powered by AI

Overview

The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model for improving hypertension control in Africa, which would ultimately reduce the risk of cardiovascular disease, stroke and kidney disease.

Eligibility

Inclusion Criteria:

  • Aged 18 -70 years.
  • Diagnosis of hypertension and elevated systolic blood pressure measure (≥140 mmHg) on the most recent clinic visit without a diabetes diagnosis.
  • Hypertension treatment naive or on monotherapy.
  • Receives primary care at one of the participating sites.
  • Willing and able to provide informed consent in English, Twi, Dagbani, Ewe, Hausa, or Yoruba.
  • Owns a smartphone (Android or iOS).

Exclusion Criteria:

  • Age \<18 years or \>70 years.
  • Severely elevated BP (≥180/110mmHg).
  • Diagnosis of stroke, coronary artery disease, or kidney disease.
  • Diagnosis of end-stage renal disease (ESRD) treated with dialysis.
  • Serious medical condition which either limits life expectancy or requires active management (e.g., cancer).
  • Cognitive impairment or other conditions preventing study participation
  • Pregnant or currently nursing a child
  • Unwilling to provide informed consent

Study details
    Hypertension
    High Blood Pressure

NCT06986590

Johns Hopkins University

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.